LUMO — Lumos Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Lumos Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	90.5	98.7	94.8	67.4	36.1
Net Total Receivables	0.824	26.3	0.128	0.223	0.21
Prepaid Expenses
Total Current Assets	94.4	128	99.7	72	40
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.37	0.584	0.635	0.283	0.603
Long Term Notes Receivable
Total Assets	96.8	129	100	72.3	40.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11.8	6.46	5.13	6.71	7.03
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	17.9	12.5	11.3	12.7	13.3
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	78.9	117	89	59.6	27.3
Total Liabilities & Shareholders' Equity	96.8	129	100	72.3	40.6
Total Common Shares Outstanding